1. Pink Sheet
  2. >>Geography

China's Shrinking Population Poses New Challenge For Pharma

Also, More COVID Drug Approvals

 
• By Brian Yang

For the first time in 61 years, China has reported its population is shrinking and the new demographic shift is likely to have a far-reaching impact on the pharma sector. Meanwhile, regulators have accelerated the approval of new COVID-19 drugs to relieve acute shortages.

China population shrinking for the first time in six decades, creates profound impact to drug making sector
Chinese population shrinks for the first time in six decades • Source: Shutterstock

China has released new official statistics that show its population declined for the first time in 61 years during 2022, an historic shift indicating the country is joining the trend in other major industrial economies and which is set to profoundly impact the health and pharma sectors. 

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from China

More from Asia